Emerging Role of GLP-1 Receptor Agonists in Managing Hidradenitis Suppurativa
Hidradenitis suppurativa (HS) remains one of dermatology’s most challenging chronic inflammatory diseases, often leaving patients with significant physical discomfort and reduced quality of life. While biologics and systemic therapies have advanced treatment options in recent years, researchers are now exploring a new therapeutic angle — the integration of GLP-1 receptor agonists into HS management plans. […]
